| Oct 24 |
Omeros gets FDA rare pediatric disease designation for renal disorder treatment
|
| Sep 3 |
Retail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%
|
| Aug 10 |
Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Omeros: Q2 Earnings Snapshot
|
| Aug 7 |
Omeros GAAP EPS of -$0.97 misses by $0.02
|
| Aug 7 |
Omeros Corporation Reports Second Quarter 2024 Financial Results
|
| Aug 6 |
Omeros Q2 2024 Earnings Preview
|
| Aug 5 |
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
|
| Jul 19 |
Omeros: Troubled Company Working Its Way Out Of The Morass
|
| Jun 4 |
Omeros Announces Webcast Details for Annual Meeting of Shareholders
|
